Genentech, Inc.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Genentech, Inc.
RECRUITINGPhase 1NCT06984341
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in...
The purpose of this study is to evaluate the safety and tolerability of P-CD19CD20-ALLO1 in participants with highly active, severe, refractory SLE with or without lupus nephritis...
Sponsor: Genentech, Inc.Enrolling: 1621 location
Systemic Lupus Erythematosus
RECRUITINGPhase 2NCT06096779
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular...
The purpose of this study is to assess the safety of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in participants with unresectable, locally...
Sponsor: Genentech, Inc.Enrolling: 3020 locations
Hepatocellular Carcinoma
RECRUITINGPhase 1 / Phase 2NCT06603246
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
This study evaluates the safety, tolerability, and activity of inhaled GDC-6988 in participants with muco-obstructive disease.
Sponsor: Genentech, Inc.Enrolling: 1287 locations
Non-cystic Fibrosis BronchiectasisChronic Obstructive Pulmonary Disease